Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74
YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor, is used to treat several different types of ophthalmology conditions
The company is targeting a Rs. 1,000 crore finished dosages business within the next five years
Jobevne is a vascular endothelial growth factor (VEGF) inhibitor that binds with VEGF and blocks the interaction with its receptors to prevent angiogenesis
This study enrolled a total of 204 healthy volunteers into three groups to compare BP16 with the reference products, Prolia, obtained from both the EU and US markets
Dr Reddy’s said scheme of amalgamation was carried with adherence to all the legal requirements including tax laws
Increases Siemens’ industrial software total addressable market by $11 billion; aligns with strategic goal to accelerate customer innovation across industries
The unique soap-fusion of Gondhoraj lime and neem provides a refreshing skin-friendly experience
Fexuprazan has the longest half-life of 9 hours among potassium-competitive acid blockers
The IND application supports the next phase of development of SBO-154
Subscribe To Our Newsletter & Stay Updated
